Overview
In a changing and expanding world, this is still the only forum designed for QPPVs by QPPVs, now in its 15th year and still going strong.
2021 Focus: The Evolution of QPPVThe QPPV Forum focuses on international QPs’ role and gives a high-level approach to the discussed topics and continues to identify key trends requiring QPPV awareness, input and oversight. This year’s objectives are built on past successes and have been shaped by valuable feedback provided by participants of the past fourteen meetings, plus many years of QPPV and Regulator interaction at this Forum. Moreover, we are looking forward to receiving information and discuss pragmatic approaches on the modern technology and how this will impact the QPPV Role.
Featured Topics
- The Role of QPPV: Evolution and Future Challenges/Expectations
- Learnings from COVID-19 Pandemic: QPPV Role and Involvement
- QPPV Requirements and Expectations in Non-EU Countries
- QPPV Oversight: Interaction between QPPV and local QPPVs, Non-EU QPPV
- UK Pharmacovigilance Requirements Post-EU Exit: Where are we now?”
- QPPV Talks
Learning Objectives
- Hear the latest updates and hot topics relating to the role of the QPPV
- Explore long term PV visions, future directions of the ‘PV world’, and potential impact on the role of the QPPV
- Network with colleagues and meet regulators
- Learn from and share experience and ideas with like-minded QPPVs in a neutral environment
- Better understand regulatory and inspectorate expectations globally
- Examine current challenges and share potential solutions
90 percent of previous participants found the forum relevant for their work. Here is why:
“A great platform of learning and exchanging the knowledge. All speakers of DIA trainings are highly experienced and they share their practical experiences which makes this event excellent. Thank you.” Phanindra Singh, 4C Pharma Solutions
An Event Designed With the QPPV Community
Featured
Want to learn more about Global Forum for Qualified Persons for Pharmacovigilance (QPPV)? You've come to the right site!
Program Committee
-
Willemijn van der Spuij, MSc Executive Director, WorldWide Patient Safety International, Europe
Switzerland -
Angela Van Der Salm, PhD, MSc Director PV, Managing partner
DADA Consultancy B.V., Netherlands -
Shahinaz Badr Pharmacovigilance Consultant and PVQA Auditor - EMEA
Pharma Quality Europe, United Arab Emirates -
Vicki Edwards, RPh Vice President, Pharmacovigilance Excellence and International QPPV
Abbvie, United Kingdom -
Gemma Jimenez Sese Senior Director, Deputy EU QPPV
AstraZeneca, Spain -
Maarten Lagendijk, MSc Deputy EU QPPV
MSD, Netherlands -
Elspeth McIntosh, MBA, RN Director
Castle Pharmacovigilance Ltd, United Kingdom -
Katarzyna Swiderek, MPharm, RPh Director, Safety Evaluation Risk Management (SERM)
GlaxoSmithKline, Poland -
Kiernan Trevett, MSc Quality Policy Lead
Genentech, A Member of the Roche Group, United States -
Nicolas Tsiakkas, MD Scientific Director
NIKOLAS TSIAKKAS AND CO OE, Greece -
Anja Van Haren, MSc Eudravigilance coordinator
Medicines Evaluation Board (MEB), Netherlands -
Magnus Ysander, MD EU & UK QPPV & Head Pharmacovigilance Excellence
AstraZeneca, Sweden
Have an account?